Radiological treatment of hepatocellular carcinoma: Trans-arterial chemoembolization and radiofrequency

被引：0
|
作者：
Rode, A. [1 ]
机构：
[1] Hop Croix Rousse, Serv Imagerie Med, 93 Grande Rue Croix Rousse, F-69004 Lyon, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2016年 / 40卷 / 06期
关键词：
Hepatocellular carcinoma; Monopolar radiofrequency; Multipolar radiofrequency; Chemoembolization; TRANSARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; ABLATION; EMBOLIZATION; THERAPY; RESECTION; INFUSION; SURVIVAL; LIVER; SIZE;
D O I：
10.1016/j.mednuc.2016.10.001
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Chemoembolization and percutaneous radiofrequency are complementary treatments for hepatocellular carcinoma (CHC). Their indications are to be regularly revalued according to the evolution of the disease: the first one is indicated in multiple but limited number lesions in patients with preserved hepatic functions. The use of microparticles did not allow to obtain an advance on the long-term survival, but standardize the method. Radiofrequency is a curative treatment, with several different devices, mono- or multipolar technologies. It preserved functional hepatic tissue and has for advantage its low rate of complications in patients in a fragile state. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：411 / 415
页数：5
相关论文
共 50 条
  • [41] Serum miR-335 Level is Associated with the Treatment Response to Trans-Arterial Chemoembolization and Prognosis in Patients with Hepatocellular Carcinoma
    Cui, Liming
    Hu, Yue
    Bai, Bin
    Zhang, Shide
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (01) : 276 - 283
  • [42] Trans-arterial embolization for hepatocellular carcinoma: with or without epidoxorubicin?
    Cucchetti, Alessandro
    Cappelli, Alberta
    Golfieri, Rita
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S208 - S211
  • [43] Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary
    Brown, Karen T.
    Do, Richard Kinh
    Gonen, Mithat
    Covey, Anne M.
    Getrajdman, George I.
    Sofocleous, Constintinos T.
    Jarnagin, William R.
    D'Angelica, Michael I.
    Allen, Peter J.
    Erinjeri, Joseph P.
    Brody, Lynn A.
    Solomon, Stephen B.
    Schwartz, Lawrence H.
    DeMatteo, Ronald P.
    Abou-Alfa, Ghassan K.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1299 - S1301
  • [44] Response to trans-arterial chemoembolization prior to orthotopic liver transplantation or hepatic resection in patients with hepatocellular carcinoma
    Almhanna, K.
    Golshayan, A.
    Sands, M.
    Levitin, A.
    Kim, R.
    Pelley, R.
    Kalmadi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
    David J. Pinato
    Madhava Pai
    Isabella Reccia
    Markand Patel
    Alexandros Giakoustidis
    Georgios Karamanakos
    Azelea Rushd
    Shiraz Jamshaid
    Alberto Oldani
    Glenda Grossi
    Mario Pirisi
    Paul Tait
    Rohini Sharma
    BMC Cancer, 18
  • [46] Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
    Pinato, David J.
    Pai, Madhava
    Reccia, Isabella
    Patel, Markand
    Giakoustidis, Alexandros
    Karamanakos, Georgios
    Rushd, Azelea
    Jamshaid, Shiraz
    Oldani, Alberto
    Grossi, Glenda
    Pirisi, Mario
    Tait, Paul
    Sharma, Rohini
    BMC CANCER, 2018, 18
  • [47] A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL
    Pinato, David J.
    Cortellini, Alessio
    Balcells, Cristina
    Killmer, Saskia
    Talbot, Thomas
    Thomas, Robert
    Sayed, Anwar A.
    Allara, Elias
    Tait, Paul
    Ross, Paul
    Young, Anna Mary
    Cole, Tom
    Goldin, Robert D.
    Ward, Caroline
    Akarca, Ayse
    Blanco, Jesus Miguens
    Marafioti, Teresa
    Keun, Hector
    Siskos, Alexandros
    Marchesi, Julian
    Bengsch, Bertram
    Sharma, Rohini
    JOURNAL OF HEPATOLOGY, 2021, 75 : S245 - S246
  • [48] Outcomes in Veterans with Hepatocellular Carcinoma (HCC) Receiving Trans-Arterial Chemoembolization (TACE) - a Single Center Experience
    Mahgoub, Amar
    Maust, Thomas J.
    McMaken, Kelly
    Knott, Astrid
    Dieperink, Eric
    Thuras, Paul
    Pocha, Christine
    HEPATOLOGY, 2013, 58 : 1267A - 1268A
  • [49] Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis
    Dai, Yanmei
    Jiang, Huijie
    Jiang, Hao
    Zhao, Sheng
    Zeng, Xu
    Sun, Ran
    Zheng, Ruoshui
    TRANSLATIONAL ONCOLOGY, 2021, 14 (12):
  • [50] Comparison of Different Bedside Scores in Predicting Recurrence Post Trans-Arterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Soriano, Christopher
    Stine, Jonathan G.
    Schreibman, Ian R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S933 - S933
12345